JULIE LUCKMAN: Open Payments
NPI 1871868208 · HORSEHEADS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,012 in 48 payments from 10 companies in 2025. Trend: 2023 $498 · 2024 $963 · 2025 $1,012
Food & beverage: $913Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $366 |
| Novartis Pharmaceuticals Corporation | 7 | $154 |
| Incyte Corporation | 6 | $122 |
| PFIZER INC. | 7 | $113 |
| ABBVIE INC. | 5 | $96 |
| Lilly USA, LLC | 3 | $63 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Botanix SB Inc | 1 | $17 |
Products named: TREMFYA, OPZELURA, CIBINQO, COSENTYX, SKYRIZI, TALTZ, Rhapsido, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
